Pages
Products

Inactivated Wild-Type Yellow Fever Virus (French Neurotropic)

For research use only. Not intended for any clinical use.

Cat. No. :   VNV-120

Inquire for Price

Virus Particles Information

Cat. No. VNV-120
Description Wild type yellow fever viruses (strain: French Neurotropic) which are inactivated by heat treatment. This product is intended for research use only.
Storage -80°C
Shipping Dry ice
Quick Inquiry

Background

Case Study

Q & A

Customer Reviews

Yellow fever virus (YFV) is a mosquito-borne flavivirus transmitted to humans primarily through the bites of infected Aedes or hematagami mosquitoes. The virus circulates in tropical and subtropical regions of Africa and South America, causing sporadic outbreaks and epidemics. Following infection, the virus replicates locally in dendritic cells before spreading to lymph nodes and disseminating through the bloodstream. Infection can manifest as a mild febrile illness or progress to severe disease characterized by high fever, jaundice, bleeding, and multi-organ failure due to liver damage (hepatotoxicity) and vascular dysfunction.

Yellow fever virus, a member of the Flaviviridae family, is an enveloped, spherical virus particle approximately 50 nanometers in diameter. The viral envelope consists of a lipid bilayer derived from the host cell membrane and contains two structural proteins: envelope protein (E), which mediates viral entry into host cells by binding to host receptors, and membrane protein (M), which stabilizes the virion. Within the envelope lies the nucleocapsid, which contains a single-stranded, positive-sense RNA genome of approximately 11 kilobases. The genome encodes a polyprotein that is cleaved by viral and host proteases into three structural proteins (C, prM, and E) and seven nonstructural proteins (NS1-NS5), which are essential for viral replication, immune evasion, and assembly. The RNA genome also possesses a 5'' translation cap and lacks the hallmark polyadenylation tail of flaviviruses. The E protein is the primary target of neutralizing antibodies and is therefore crucial for vaccine development.

Several studies have implicated viral infection-induced oxidative stress as one of its pathogenesis. Here, researchers evaluated whether yellow fever virus (YFV) infection of human hepatocytes induces an imbalance in redox homeostasis, ultimately leading to oxidative stress. YFV infection resulted in a significant increase in reactive oxygen species (ROS) levels from 2 to 4 days post infection (dpi). When oxidative parameters were measured at 4 dpi, YFV infection caused oxidative damage to lipids, proteins, and DNA, as evidenced by increases in lipid peroxidation/8-isoprostanes, carbonyl proteins, and 8-hydroxy-2′-deoxyguanosine. In addition, the activities of the antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx) were significantly reduced, and the ratio of reduced glutathione to oxidized glutathione (GSH/GSSG) was also reduced, indicating a pro-oxidative environment. However, no changes were observed in the enzymatic activity of catalase (CAT) and the gene expression of SOD isoforms (1/2/3), CAT, or GPx. Thus, these results suggest that yellow fever virus (YFV) infection causes an imbalance in redox homeostasis, leading to overproduction of reactive oxygen species (ROS) and depletion of antioxidant enzymes, thus inducing oxidative damage to cellular components.

ROS quantification was performed from 1 dpi to 5 dpi of infection (Figure 1). At 1 dpi of infection, ROS levels in YFV-infected cells were at baseline, while no difference was observed in inactivated YFV-infected cells (control) (Figure 1a). From 2 dpi to 4 dpi of infection, ROS production in YFV-infected cells gradually increased, with significant differences compared to the cell control, while no difference was observed compared to the positive control (H2O2) at 3 dpi and 4 dpi of infection (Figure 1b-d). At 5 dpi of infection, ROS levels in YFV-infected cells were very close to those of control cells (Figure 1e). This was expected, as it has been observed that at 5 dpi of infection, cells begin to be damaged by the lack of nutrients in the culture medium and the acidic pH. Since the cell death process itself naturally increases ROS, and the results were normalized by the fluorescence level of control cells, no statistical difference was observed between control and yellow fever virus-infected cells at 5 dpi. At all dpi, infection of cells with UV-inactivated YFV did not stimulate ROS production, indicating that the exacerbated production of ROS is related to the viral activity and multiplication of YFV in hepatocytes, and not just the presence of viral particles themselves.

Yellow fever virus (YFV) infection of human hepatocytes increases levels of reactive oxygen species (ROS).Figure 1. Yellow fever virus (YFV) infection of human hepatocytes increases levels of reactive oxygen species (ROS). (Ferraz A C, et al., 2024)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Great service!

The Inactivated Yellow Fever Virus was exactly as described. Creative Biogene’s attention to detail in packaging and documentation was impressive. Their team even checked in post-delivery to confirm everything was in order—great service!

French

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction